Latest Sanofi Consumer Healthcare stock price
Sanofi Consumer Healthcare P/E Ratio
SANOFICONR • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
46.4
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
46.4
Current Price
₹4464.10
EPS (TTM)
₹78.59
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
57.45
Sector Median
35.38
Sector Rank
#11 of 88
Sector Percentile
12.5%
Key P/E Ratio Insights for Sanofi Consumer Healthcare
- Stock appears overvalued with PE of 46.4, suggesting caution for new investments
- Trading at discount to sector average PE of 57.45
View the SANOFICONR equity price for detailed stock performance.
Related Pages for Sanofi Consumer Healthcare
Additional stock information and data for SANOFICONR
Sector P/E Ratio Comparison
Comparing Sanofi Consumer Healthcare with other companies in Healthcare sector
Sector Average
57.45
Sector Median
35.38
Lowest P/E
9.01
Highest P/E
515.32
Companies
88
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |
| Lincoln Pharmaceuticals | LINCOLN | 12.02 | ₹974 | Low |
| QMS Medical Allied Servi… | QMSMEDI | 12.82 | ₹177 | Low |
| Take Solutions | TAKE | 13.15 | ₹638 | Low |
| Venus Remedies | VENUSREM | 14.27 | ₹995 | Low |
| Royal Sense | ROYAL | 14.5 | ₹96 | Low |
| Bliss GVS Pharma | BLISSGVS | 16.62 | ₹1,973 | Moderate |
| RPG Life Sciences | RPGLIFE | 17.94 | ₹3,861 | Moderate |